Does CERTOLIZUMAB Cause Mobility decreased? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Mobility decreased have been filed in association with CERTOLIZUMAB. This represents 1.1% of all adverse event reports for CERTOLIZUMAB.
6
Reports of Mobility decreased with CERTOLIZUMAB
1.1%
of all CERTOLIZUMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From CERTOLIZUMAB?
Of the 6 reports, 1 (16.7%) resulted in death, 2 (33.3%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB Cause?
Drug ineffective (156)
Infection (71)
Off label use (64)
Rheumatoid arthritis (53)
Drug intolerance (51)
Arthritis (44)
Therapeutic product effect decreased (39)
Condition aggravated (36)
Treatment failure (36)
Pneumonia (35)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CERTOLIZUMAB Alternatives Have Lower Mobility decreased Risk?
CERTOLIZUMAB vs CERTOLIZUMAB PEGOL
CERTOLIZUMAB vs CERTOPARIN
CERTOLIZUMAB vs CETIRIZINE
CERTOLIZUMAB vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB vs CETRIMIDE